Menu
GeneBe

rs750958357

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting

The NM_030962.4(SBF2):c.5014_5016del(p.Lys1672del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000444 in 1,614,134 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K1672K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00063 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00042 ( 0 hom. )

Consequence

SBF2
NM_030962.4 inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:8

Conservation

PhyloP100: 5.72
Variant links:
Genes affected
SBF2 (HGNC:2135): (SET binding factor 2) This gene encodes a pseudophosphatase and member of the myotubularin-related protein family. This gene maps within the CMT4B2 candidate region of chromosome 11p15 and mutations in this gene have been associated with Charcot-Marie-Tooth Disease, type 4B2. [provided by RefSeq, Jul 2008]
SBF2-AS1 (HGNC:27438): (SBF2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_030962.4. Strenght limited to Supporting due to length of the change: 1aa.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SBF2NM_030962.4 linkuse as main transcriptc.5014_5016del p.Lys1672del inframe_deletion 36/40 ENST00000256190.13
SBF2-AS1NR_036485.1 linkuse as main transcriptn.212-20193_212-20191del intron_variant, non_coding_transcript_variant
LOC105369149XR_007062587.1 linkuse as main transcriptn.355+2879_355+2881del intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SBF2ENST00000256190.13 linkuse as main transcriptc.5014_5016del p.Lys1672del inframe_deletion 36/401 NM_030962.4 P3Q86WG5-1
SBF2-AS1ENST00000663578.1 linkuse as main transcriptn.237-20193_237-20191del intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.000631
AC:
96
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000779
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.000457
AC:
115
AN:
251476
Hom.:
0
AF XY:
0.000544
AC XY:
74
AN XY:
135912
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000520
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000425
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000589
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000424
AC:
620
AN:
1461818
Hom.:
0
AF XY:
0.000446
AC XY:
324
AN XY:
727214
show subpopulations
Gnomad4 AFR exome
AF:
0.000119
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.000995
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000336
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000453
Gnomad4 OTH exome
AF:
0.000381
GnomAD4 genome
AF:
0.000630
AC:
96
AN:
152316
Hom.:
0
Cov.:
32
AF XY:
0.000671
AC XY:
50
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.00170
Gnomad4 ASJ
AF:
0.00144
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000779
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.000158
Hom.:
0
Bravo
AF:
0.000737
EpiCase
AF:
0.000600
EpiControl
AF:
0.00124

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 27, 2022Identified along with a second SBF2 variant in a patient with spastic paraplegia and leukodystrophy, but segregation information was not provided (Nagappa et al., 2018); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27582484, 30212743, 26392352) -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsAug 04, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2017- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMar 13, 2018- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 26, 2023The c.5014_5016delAAA (p.K1672del) alteration is located in exon 36 (coding exon 36) of the SBF2 gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.5014 and c.5016, resulting in the deletion of 1 residue. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Peripheral neuropathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingClaritas GenomicsAug 22, 2016- -
Charcot-Marie-Tooth disease type 4B2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenomic Research Center, Shahid Beheshti University of Medical SciencesDec 18, 2017- -
Charcot-Marie-Tooth disease type 4 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 18, 2022This variant, c.5014_5016del, results in the deletion of 1 amino acid(s) of the SBF2 protein (p.Lys1672del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs750958357, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SBF2-related conditions. ClinVar contains an entry for this variant (Variation ID: 397621). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs750958357; hg19: chr11-9809201; API